. Initial non-contrast head computed tomography with hyperdense middle cerebral artery sign (arrow) medicine consultation. She received 4 units of fresh frozen plasma and 2 units of packed red cells. The patient remained intubated and on mechanical ventilation for 10 days. Follow-up chest CT and X-ray imaging taken after one month showed complete resolution of the infiltrates. The patient was transferred to the palliative care unit at one month after administration with a modified Rankin scale score of 5.
Diffuse alveolar hemorrhage is a very rare, life-threatening complication of iv. lytic therapy and should be considered in patients with hemoptysis, pulmonary infiltrates, and acute anemia after thrombolysis (1) . There are some reports related to alveolar hemorrhage with thrombolytic therapy after myocardial infarction (2, 3) . This is the first case of pulmonary alveolar hemorrhage in a patient with stroke after thrombolytic therapy.
The exact incidence of this complication is unknown. It usually occurs within a few hours to five days after the thrombolytic treatment. There are some predisposing factors related to intra-alveolar hemorrhage including immunodeficiency, pneumonia, chronic obstructive pulmonary disease, congestive heart failure, and tobacco and cocaine use (3, 4) . In our patient, hemoptysis started 12 hours after the treatment and none of abovementioned predisposing factors existed. On the other hand, the patient had atrial fibrillation and mitral stenosis associated with rheumatic fever. The presence of alveolar bleeding in this patient might be related to valvular atrial fibrillation.
Management of diffuse alveolar hemorrhage consists of treatment of respiratory failure and anemia (5) . Sometimes respiratory failure may require ventilation, as the anemia requires transfusion of packed cells. Our patient required mechanical ventilation for 10 days, and packed red cell transfusions were given twice. 
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